GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cellsex vivo-Reference-Cited by-同舟云学术

GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cellsex vivo

Published:2015-05-29 Issue:12 Volume:4 Page:e1051297
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Pedroza-Gonzalez Alexander,Zhou Guoying,Singh Simar Pal,Boor Patrick PC,Pan Qiuwei,Grunhagen Dirk,de Jonge Jeroen,Tran TC Khe,Verhoef Cornelis,IJzermans Jan NM,Janssen Harry LA,Biermann Katharina,Kwekkeboom Jaap,Sprengers Dave

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1051297

Reference41 articles.

1. Hepatocellular carcinoma: an overview

2. Estimating the world cancer burden: Globocan 2000

3. Repeat Curative Intent Liver Surgery is Safe and Effective for Recurrent Colorectal Liver Metastasis: Results from an International Multi-institutional Analysis

4. Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution

5. Diagnosis and Treatment of Hepatocellular Carcinoma

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma;Cancers;2024-07-22

2. Strategic advancement of E3 ubiquitin ligase in the management of hepatocellular carcinoma;Medical Oncology;2024-06-18

3. Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma;Translational Oncology;2024-04

4. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake;Frontiers in Immunology;2024-02-19

5. Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity;Frontiers in Immunology;2024-01-12